ENSG — The Ensign Group, Inc. stock price, charts and financials

QT48The Ensign Group, Inc.

The Ensign Group, Inc. (NASDAQ: ENSG) is a Healthcare company in the Medical - Care Facilities industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
176.13
-1.10-0.62%
ENSGQT48The Ensign Group, Inc.·NASDAQ
176.13-0.62%
News
Down 0.6% — Lowey Dannenberg, P.C. is Investigating The Ensign Group (NASDAQ: ENSG) for Potential Violations of the Federal Securities Laws (globenewswire.com).
Medium confidence
TA
Loading chart...
Screen all →
Snapshot
Index-P/E27.61EPS (ttm)6.38Insider Own3.05%Shs Outstand58.28MPerf Week-3.83%
Market Cap10.27BForward P/E20.59EPS next Y8.55Insider Trans-1.08%Shs Float56.19MPerf Month5.57%
Enterprise Value12.07BPEG2.88EPS next Q1.92Inst Own-Short Float3.85%Perf Quarter-3.24%
Income379.00MP/S1.87EPS this Y22.17%Inst Trans-Short Ratio2.69Perf Half Y2.07%
Sales5.49BP/B4.20EPS next Y9.73%ROA6.59%Short Interest2.17MPerf YTD1.11%
Book/sh41.95P/C31.98EPS next 5Y9.60%ROE16.53%52W High218.01 -19.21%Perf Year16.07%
Cash/sh5.51P/FCF24.78EPS past 3/5Y13.92% 13.80%ROIC7.12%52W Low141.58 24.40%Perf 3Y89.29%
Dividend Est.0.26 (0.15%)EV/EBITDA19.44Sales past 3/5Y18.69% 16.05%Gross Margin14.14%Volatility2.28% 2.51%Perf 5Y105.95%
Dividend TTM0.26 (0.15%)EV/Sales2.20EPS Y/Y TTM24.61%Oper. Margin8.52%ATR (14)5.24Perf 10Y762.96%
Dividend Ex-DateJun 30, 2026Quick Ratio1.21Sales Y/Y TTM28.78%Profit Margin6.90%RSI (14)56.41Recom2.46
Dividend Gr. 3/5Y4.31% 4.51%Current Ratio1.21EPS Q/Q20.75%SMA201.81%Beta0.69Target Price220.00
Payout3.91%Debt/Eq1.81Sales Q/Q17.26%SMA505.83%Rel Volume0.53Prev Close177.23
Employees46,000LT Debt/Eq1.81EarningsNov 02SMA200-3.65%Avg Volume822.31KPrice176.13
IPO DateNov 09, 2007Option/ShortYes / YesEPS/Sales Surpr.3.91% -0.08%Net Debt/EBITDA3.20Volume438,102Change-0.62%
Analyst Ratings
DateActionAnalystRatingTarget
Jul-28-26ReiteratedRBC CapitalOutperform$222$228
Jul-14-26ReiteratedTruist SecuritiesHold$215$202
Feb-09-26ReiteratedRBC CapitalOutperform$206$222
Feb-06-26ReiteratedUBSBuy$220$230
Feb-06-26ReiteratedTruist SecuritiesHold$200$215
Nov-14-25ReiteratedRBC CapitalOutperform$167$206
Nov-10-25ReiteratedTruist SecuritiesHold$190$200
Nov-05-25ReiteratedUBSBuy$205$220
Oct-14-25ReiteratedTruist FinancialHold$165$190
Sep-02-25ReiteratedUBSBuy$205
Latest News
Aug-04-26
Aug-03-26
Jul-31-26
Jul-30-26
Jul-29-26
Company

The Ensign Group, Inc. operates as a healthcare provider, primarily concentrating on post-acute care services, alongside other supporting business ventures. The company's activities are organized into two main divisions: Skilled Services and Real Estate. Within its Skilled Services segment, Ensign provides extensive short-term and long-term nursing care tailored for patients recovering from extended illnesses, managing chronic health conditions, or requiring elder care. This division also encompasses a variety of rehabilitative therapies, such as physical, occupational, and speech therapy, among other specialized healthcare provisions. Beyond direct medical care, the company furnishes essential amenities like lodging, customized dietary programs, and opportunities for social engagement, recreation, and entertainment. Ensign additionally manages senior living facilities and delivers convenient mobile diagnostic services. Its diverse array of supplementary services includes digital X-rays, ultrasounds, electrocardiograms, laboratory analyses, sub-acute care, and patient transportation, which can be provided either in patients' residences or at long-term care facilities. The company also engages in the leasing of real estate properties. As of April 4, 2022, Ensign operated a network of 252 healthcare facilities spread across thirteen U.S. states: Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington, and Wisconsin. The Ensign Group, Inc. was established in 1999 and is headquartered in San Juan Capistrano, California.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue5,4865,0584,2603,7293,0252,6272,4032,0371,755
Cost of Goods Sold Incl. D&A4,7114,2583,5933,1392,5072,1591,9951,7451,536
Gross Profit776799668591518468407291219
Selling, General and Administrative Excl. Other29827022526315915213011191
Research and Development
000000000
Other Operating Expense1010484726256545143
Operating Income46842535825529726022312985
Interest Expense88889791615
Unusual Expense
Non-Operating Income (Expense)3938362514432
Net Income Before Taxes50045638627328925821811672
Income Taxes12111188636460462413
Consolidated Net Income37934429820922519517011192
Net Income From Continuing Operations3803442982102251981719259
Net Income37934429820922519517011192
EPS (Recurring)6.576.005.263.764.093.573.192.071.78
EPS (Basic, Before Extraordinaries)6.576.005.263.764.093.573.192.071.78
EPS (Diluted)6.385.845.123.653.953.423.061.971.70
EBITDA621568479353360321282183132
Other After Tax Adjustments
Stock Option Compensation Expense
Price To Earnings Ratio27.6129.8325.9530.7423.9524.5523.8323.0321.34
Price To Sales Ratio1.861.961.781.691.721.731.611.181.07
Gross Margin14.1515.8015.6815.8517.1217.8116.9414.2912.48
Operating Margin8.538.408.406.849.829.909.286.334.84
Net Margin6.916.807.005.607.447.427.075.455.24
Shares Outstanding585757565554535352
Market Capitalization10,2169,9297,5736,2845,2044,5343,8652,4051,886
Operating Lease Expense
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$227.75$201.92$176.10$150.27$124.44 Close Price0.00M1.90M3.79M5.69M7.59MUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Blouin Ann ScottDirectorJul 27 '26Sale183.5437568,82923,677Jul 29
Agwunobi John ODirectorJul 20 '26Sale171.0639267,0569,503Jul 22
Parkinson Mark VincentDirectorJul 16 '26Sale168.1210016,8123,900Jul 17
SMITH BARRY MDirectorJun 02 '26Sale164.28700114,99621,352Jun 04
SMITH BARRY MDirectorMay 04 '26Sale182.21700127,54722,052May 06
Agwunobi John ODirectorApr 20 '26Sale199.9739278,3889,295Apr 22
Parkinson Mark VincentDirectorApr 16 '26Sale196.6010019,6603,400Apr 17
SMITH BARRY MDirectorApr 02 '26Sale196.65700137,65522,152Apr 06
SMITH BARRY MDirectorMar 02 '26Sale213.02700149,11422,852Mar 02
Uychiat Pison MarivicDirectorFeb 20 '26Sale204.926713,73014,340Feb 20
Wittekind Beverly B.VP and Chief Legal OfficerFeb 19 '26Option Exercise83.6450041,82033,279Feb 20
Uychiat Pison MarivicDirectorFeb 19 '26Sale211.028317,51414,407Feb 20
Wittekind Beverly B.VP and Chief Legal OfficerFeb 19 '26Sale210.23500105,11532,779Feb 20
Shaw DarenDirectorFeb 17 '26Sale213.431,000213,43023,726Feb 19
Parkinson Mark VincentDirectorFeb 09 '26Sale198.0010019,8002,900Feb 09
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.